The pharmaceutical business stated early trial outcomes of its anti-viral COVID tablet, PAXLOVID, decreases danger of being hospitalized or passing away by 89%.
LEARNT MORE: https://abcn.ws/3EMZz42
#ABCNews #Pfizer #Paxlovid #COVIDPill.
https://covid19globalcases.com/pfizer-launches-early-trial-outcomes-of-covid-19-tablet-l-gma/
Comments
Post a Comment